Teva: Our Biosimilars Strategy Has Been Fragmented, We Want To Be Global

Israeli Firm ‘Absolutely’ Believes Biosimilars Are Long-Term Growth Driver

 
• By Dean Rudge
  
Globe hands (otnaydur/Shutterstock.com)
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products